Norway Savings Bank’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,074
| Closed | -$348K | – | 108 |
|
|
2025
Q1 | $348K | Sell |
3,074
-5,497
| -64% | -$588K | 0.2% | 89 |
|
|
2024
Q4 | $905K | Sell |
8,571
-486
| -5% | -$52.1K | 0.5% | 63 |
|
|
2024
Q3 | $978K | Sell |
9,057
-1,462
| -14% | -$160K | 0.53% | 65 |
|
|
2024
Q2 | $1.14M | Sell |
10,519
-355
| -3% | -$41.8K | 0.65% | 54 |
|
|
2024
Q1 | $1.44M | Sell |
10,874
-51
| -0.5% | -$6.37K | 0.6% | 60 |
|
|
2023
Q4 | $1.33M | Sell |
10,925
-235
| -2% | -$26.2K | 0.59% | 60 |
|
|
2023
Q3 | $1.25M | Buy |
11,160
+755
| +7% | +$95.9K | 0.62% | 59 |
|
|
2023
Q2 | $1.51M | Buy |
10,405
+170
| +2% | +$23.1K | 0.83% | 45 |
|
|
2023
Q1 | $1.32M | Sell |
10,235
-310
| -3% | -$38.9K | 0.67% | 55 |
|
|
2022
Q4 | $1.34M | Sell |
10,545
-62
| -0.6% | -$7.2K | 0.68% | 54 |
|
|
2022
Q3 | $1.11M | Buy |
10,607
+125
| +1% | +$13.7K | 0.61% | 59 |
|
|
2022
Q2 | $1.1M | Buy |
10,482
+385
| +4% | +$45.7K | 0.57% | 58 |
|
|
2022
Q1 | $1.29M | Sell |
10,097
-427
| -4% | -$51.5K | 0.58% | 57 |
|
|
2021
Q4 | $1.3M | Buy |
10,524
+57
| +0.5% | +$7.46K | 0.57% | 63 |
|
|
2021
Q3 | $1.49M | Buy |
10,467
+1,035
| +11% | +$152K | 0.7% | 48 |
|
|
2021
Q2 | $1.47M | Buy |
9,432
+320
| +4% | +$51.8K | 0.72% | 47 |
|
|
2021
Q1 | $1.42M | Buy |
9,112
+587
| +7% | +$90.9K | 0.75% | 45 |
|
|
2020
Q4 | $1.27M | Sell |
8,525
-16
| -0.2% | -$2.26K | 0.73% | 45 |
|
|
2020
Q3 | $1.13M | Buy |
8,541
+479
| +6% | +$62.6K | 0.76% | 42 |
|
|
2020
Q2 | $934K | Buy |
8,062
+314
| +4% | +$36.2K | 0.69% | 47 |
|
|
2020
Q1 | $760K | Buy |
7,748
+549
| +8% | +$72K | 0.66% | 49 |
|
|
2019
Q4 | $1.05M | Buy |
7,199
+464
| +7% | +$64K | 0.76% | 40 |
|
|
2019
Q3 | $897K | Sell |
6,735
-237
| -3% | -$30.6K | 0.73% | 40 |
|
|
2019
Q2 | $797K | Buy |
6,972
+819
| +13% | +$95.9K | 0.68% | 42 |
|
|
2019
Q1 | $762K | Buy |
6,153
+26
| +0.4% | +$2.96K | 0.67% | 43 |
|
|
2018
Q4 | $617K | Buy |
6,127
+168
| +3% | +$18.9K | 0.6% | 48 |
|
|
2018
Q3 | $761K | Sell |
5,959
-303
| -5% | -$36K | 0.66% | 46 |
|
|
2018
Q2 | $678K | Sell |
6,262
-351
| -5% | -$38.2K | 0.62% | 49 |
|
|
2018
Q1 | $699K | Sell |
6,613
-293
| -4% | -$34K | 0.66% | 47 |
|
|
2017
Q4 | $809K | Sell |
6,906
-768
| -10% | -$86.8K | 0.76% | 41 |
|
|
2017
Q3 | $873K | Sell |
7,674
-195
| -2% | -$22.5K | 0.84% | 39 |
|
|
2017
Q2 | $981K | Buy |
7,869
+396
| +5% | +$46.9K | 0.96% | 31 |
|
|
2017
Q1 | $886K | Sell |
7,473
-2,812
| -27% | -$319K | 0.91% | 34 |
|
|
2016
Q4 | $1.03M | Buy |
+10,285
| New | +$1.1M | 0.96% | 34 |
|
Other funds holding ZBH
Norway Savings Bank's ZBH Position: Q2 2025 in Review
Norway Savings Bank sold out of Zimmer Biomet (ZBH) in Q2 2025, closing a stake of 3,074 shares — an estimated $348K sold.
Norway Savings Bank first reported a position in ZBH in Q4 2016 and held it in 34 quarters. The position peaked at $1.51M in Q2 2023. 934 funds tracked by Wall St. Rank hold ZBH as of Q2 2025.
- Norway Savings Bank reported no remaining Zimmer Biomet position as of Q2 2025 after selling out during the quarter.
- Norway Savings Bank sold 3,074 Zimmer Biomet shares in Q2 2025, an estimated $348K.
- Norway Savings Bank first reported a position in Zimmer Biomet in Q4 2016 and held it in 34 quarters.
- Norway Savings Bank's Zimmer Biomet position peaked at $1.51M in Q2 2023.
- 934 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2025.
Based on Norway Savings Bank's 13F filing for Q2 2025, filed 2 Jul 2025.